Auto-immune risks of hepatitis B vaccination: a clue on biological plausibility.

[Sheri Nakken]

Auto-immune risks of hepatitis B vaccination: a clue on biological
plausibility.
Dr Marc Girard (Versailles, France), a specialist in the side-effects
of drugs, was commissioned as a medical expert witness by French
courts, and spent thousands of hours evaluating the problems related
to hepatitis B vaccination. Although most of his results remain
confidential by court order, Dr. Girard recently disclosed evidence
demonstrating that this specific vaccine is remarkable by the unusual
frequency, severity and variety of its adverse events (Autoimmun Rev
2005; 4: 96-100). He also reported that studies performed by the
French health authorities and revealing clear auto-immune risks have
remained unpublished.
Apparently concerned by the strength of the clinical and
epidemiological evidence presented, leading experts in auto-immunity
wrote an accompanying editorial challenging the author to provide
credible mechanisms for these toxic effects (Autoimmun Rev 2005; 4: 79-81).
In a publication now in press in Medical Hypotheses and currently
available on line, Drs. Comenge and Girard discuss the toxicity
spectrum of the Hepatitis B vaccine and its clinical manifestations,
namely: 1) vaccine-induced findings of hepatitis B (as predicted
quite earlier during the development of the vaccine); 2) central
demyelinating diseases, the epidemiological evidence of which is
beyond reasonable doubt, and which might be triggered by minute
amounts of a viral polymerase protein contaminating the vaccine.
Because of the significance and scope of these observations, Dr.
Girard suggests that even in highly-endemic countries, the
risk/benefit ratio of this unusually toxic vaccine must be carefully
re-assessed.
Important new study by Marc Girard and Yannick Comenge regarding the
safety of Hepatitis B vaccine (currently proposed by the British
Medical Association for addition to the UK infant schedule).
PDF FILE of article
http://www.nccn.net/~wwithin/girardhepbvax.pdf
Multiple sclerosis and hepatitis B vaccination:
Adding the credibility of molecular biology
to an unusual level of clinical and
epidemiological evidence
Yannick Comenge
a
, Marc Girard
b, *
Received 29 July 2005; accepted 1 August 2005
Summary In spite of a huge number of reports of severe hazards after
injection of hepatitis B vaccine (HBV), the
issue is regularly raised that no mechanism is available for the
development of central demyelinating disorders such as
multiple sclerosis (MS). A number of convergent facts, however,
suggests that the manufacturing process could
introduce HBV polymerase as a contaminant, and then trigger an
auto-immune process against myelin in some
vaccinated subjects. Of great significance, this hypothesis is likely
to give the missing link to account for the
considerable body of clinical and epidemiological evidence
documenting that, for a drug used with a preventive
purpose, HBV has an unusual potential to induce central neurological
disorders amongst others unwanted side-effects.
c 2005 Elsevier Ltd. All rights reserved.
Sheri Nakken, former R.N., MA, Hahnemannian Homeopath
http://homeopathycures.wordpress.com/ &
http://vaccinationdangers.wordpress.com/
ONLINE/Email classes in Homeopathy; Vaccine Dangers; Childhood Diseases